Advertisement
Demo

Merck shares jump after combination trial shows Keytruda extends lung cancer survival

Jan 17, 2018 , CNBC Health
Merck's blockbuster drug Keytruda in combination with two chemotherapy drugs was successful as a first line treatment for lung cancer.

Read the full story...


Trending healthcare news keywords at this moment

trump healthcare congo ebola study fish heart disease blood women tip fda drug cancer patients tied risk care medicaid lower work hospitals pay day pain safety vitamin linked finds pregnancy case prices treatment death million products diet lung teething latest